Tudor Investment Corp
AVDL

Tudor Investment Corp’s Avadel Pharmaceuticals AVDL Stock Holding History

Tudor Investment Corp’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,983,541
Closed -$64.3M – 3595
2025
Q4 		$64.3M Buy
2,983,541
+2,939,779
+6,718% +$57.1M 0.12% 123
2025
Q3 		$668K Buy
+43,762
New +$569K ﹤0.01% 2529
2025
Q2 		– Sell
-50,960
Closed -$399K – 3235
2025
Q1 		$399K Buy
+50,960
New +$427K ﹤0.01% 2421
2024
Q4 		– Sell
-55,525
Closed -$728K – 2999
2024
Q3 		$728K Buy
+55,525
New +$846K ﹤0.01% 1807

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Tudor Investment Corp's AVDL Position: Q1 2026 in Review

Tudor Investment Corp sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 2,983,541 shares — an estimated $64.3M sold.

Tudor Investment Corp first reported a position in AVDL in Q3 2024 and held it in 4 quarters. The position peaked at $64.3M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Tudor Investment Corp reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Tudor Investment Corp sold 2,983,541 Avadel Pharmaceuticals shares in Q1 2026, an estimated $64.3M.
  • Tudor Investment Corp first reported a position in Avadel Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Tudor Investment Corp's Avadel Pharmaceuticals position peaked at $64.3M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.